Spero Therapeutics (SPRO) News Today

→ Now Open: Crypto emergency update (From InvestorPlace) (Ad)

$1.47

-0.03 (-2.00%)

(As of 04/18/2024 ET)

Source

Source	Headline
	Spero Therapeutics (NASDAQ:SPRO) Stock Passes Above 200-Day Moving Average of $1.40 americanbankingnews.com - April 12 at 3:04 AM
	Spero Therapeutics (NASDAQ:SPRO) Rating Reiterated by Cantor Fitzgerald marketbeat.com - April 4 at 10:16 AM
	HC Wainwright Comments on Spero Therapeutics, Inc.'s Q1 2024 Earnings (NASDAQ:SPRO) marketbeat.com - March 20 at 5:45 AM
	HC Wainwright Weighs in on Spero Therapeutics, Inc.'s FY2025 Earnings (NASDAQ:SPRO) marketbeat.com - March 19 at 7:30 AM
	Spero Therapeutics (NASDAQ:SPRO) Given Buy Rating at HC Wainwright marketbeat.com - March 18 at 5:31 PM
	Spero Therapeutics’ Robust Drug Pipeline and Positive Trial Advancements Prompt Buy Rating markets.businessinsider.com - March 18 at 4:28 PM
	Spero Therapeutics, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year finance.yahoo.com - March 17 at 1:50 PM
	Spero Therapeutics, Inc. (NASDAQ:SPRO) Q4 2023 Earnings Call Transcript finance.yahoo.com - March 15 at 1:16 PM
	Spero Therapeutics, Inc.'s (NASDAQ:SPRO) Stock's On An Uptrend: Are Strong Financials Guiding The Market? finance.yahoo.com - March 15 at 8:16 AM
	Spero Therapeutics, Inc.: Spero Therapeutics Announces Fourth Quarter and Full Year 2023 Operating Results and Provides a Business Update finanznachrichten.de - March 14 at 3:28 PM
	Q4 2023 Spero Therapeutics Inc Earnings Call finance.yahoo.com - March 14 at 10:28 AM
	TD Cowen Sticks to Its Hold Rating for Spero Therapeutics (SPRO) markets.businessinsider.com - March 14 at 5:27 AM
	Recap: Spero Therapeutics Q4 Earnings benzinga.com - March 13 at 10:34 PM
	Spero Therapeutics GAAP EPS of $0.96 beats by $1.06, revenue of $73.5M beats by $54.87M msn.com - March 13 at 5:34 PM
	Spero Therapeutics Announces Fourth Quarter and Full Year 2023 Operating Results and Provides a Business Update globenewswire.com - March 13 at 4:01 PM
	Spero Therapeutics Q4 2023 Earnings Preview msn.com - March 12 at 9:15 PM
	Spero Therapeutics (SPRO) to Announce Quarterly Earnings on Wednesday marketbeat.com - March 7 at 1:07 PM
	Spero Therapeutics to Provide Business Update and Report Fourth Quarter and Full Year 2023 Financial Results on Wednesday, March 13, 2024 globenewswire.com - March 6 at 8:05 AM
	Spero Therapeutics, Inc.: Spero Therapeutics Announces Clearance of IND for SPR206 to Treat MDR Gram-negative Bacterial Infections finanznachrichten.de - February 28 at 1:33 PM
	Spero Announces FDA Clearance Of IND Application For SPR206 markets.businessinsider.com - February 28 at 1:33 PM
	Spero Therapeutics Announces Clearance of IND for SPR206 to Treat MDR Gram-negative Bacterial Infections finance.yahoo.com - February 28 at 8:33 AM
	Spero Therapeutics Announces Clearance of IND for SPR206 to Treat MDR Gram-negative Bacterial Infections globenewswire.com - February 28 at 8:05 AM
	Spero Therapeutics to Present at Cowen’s 44th Annual Healthcare Conference finance.yahoo.com - February 26 at 10:15 AM
	Spero Therapeutics to Present at Cowen's 44th Annual Healthcare Conference globenewswire.com - February 26 at 8:05 AM
	SPRO Apr 2024 1.000 call ca.finance.yahoo.com - February 17 at 2:46 PM
	SPRO Apr 2024 2.000 put ca.finance.yahoo.com - February 17 at 2:46 PM
	Spero Therapeutics Announces Chief Legal Officer’s Resignation msn.com - February 10 at 1:40 PM
	Spero Therapeutics (NASDAQ:SPRO) Stock Price Passes Above 200-Day Moving Average of $1.31 marketbeat.com - February 10 at 4:12 AM
	Spero Therapeutics Inc (SPRO) uk.investing.com - February 9 at 10:26 AM
	Spero Therapeutics Inc CEO Sath Shukla Sells 75,994 Shares finance.yahoo.com - February 6 at 6:05 AM
	Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) finance.yahoo.com - January 31 at 9:07 PM
	Spero Therapeutics, Inc. (NASDAQ:SPRO): Are Analysts Optimistic? finance.yahoo.com - January 19 at 2:29 PM
	Spero Therapeutics, Inc.: Spero Therapeutics Provides Corporate Update and 2024 Outlook finanznachrichten.de - January 5 at 4:37 PM
	Spero Therapeutics says cash and cash equivalents as of December 31 were about $76.3M msn.com - January 5 at 8:44 AM
	Spero Therapeutics Provides Corporate Update and 2024 Outlook finance.yahoo.com - January 5 at 8:44 AM
	Spero Therapeutics’ Promising Outlook: Clinical Milestones and Strategic GSK Partnership markets.businessinsider.com - January 4 at 2:53 PM
	Spero Therapeutics Announces First Patient, First Visit for Phase 3 PIVOT-PO Trial Evaluating Tebipenem HBr in Complicated Urinary Tract Infections finance.yahoo.com - January 2 at 9:29 AM
	Spero Therapeutics Announces First Patient, First Visit for Phase 3 PIVOT-PO Trial Evaluating Tebipenem HBr in Complicated Urinary Tract Infections finance.yahoo.com - January 2 at 9:29 AM
	Spero Therapeutics, Inc. (NASDAQ:SPRO) Q3 2023 Earnings Call Transcript finance.yahoo.com - November 14 at 1:01 PM
	Spero Therapeutics, Inc.: Spero Therapeutics Announces Third Quarter 2023 Operating Results and Provides a Business Update finanznachrichten.de - November 14 at 8:00 AM
	Recap: Spero Therapeutics Q3 Earnings benzinga.com - November 13 at 8:46 PM
	Spero Therapeutics Announces Third Quarter 2023 Operating Results and Provides a Business Update finance.yahoo.com - November 13 at 8:46 PM
	Spero Therapeutics Q3 2023 Earnings Preview msn.com - November 12 at 8:55 PM
	Here's what Wall Street expects from Spero Therapeutics's earnings report markets.businessinsider.com - November 12 at 3:30 PM
	Spero Therapeutics to Provide Business Update and Report Third Quarter 2023 Financial Results on Monday, November 13, 2023 finance.yahoo.com - November 6 at 11:29 AM
	SPERO ALERT: Bragar Eagel & Squire, P.C. is Investigating Spero Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm businesswire.com - November 2 at 10:58 PM
	Spero Therapeutics to Present at Upcoming November Investor Conferences finance.yahoo.com - November 1 at 8:43 PM
	Spero Therapeutics, Inc.: Spero Therapeutics Appoints Esther Rajavelu as Chief Financial Officer and Chief Business Officer finanznachrichten.de - November 1 at 10:42 AM
	All You Need to Know About Spero Therapeutics, Inc. (SPRO) Rating Upgrade to Buy finance.yahoo.com - October 18 at 2:11 PM
	Spero Therapeutics to Present at Cantor’s Global Healthcare 2023 Investor Conference finance.yahoo.com - September 20 at 8:20 PM

Get Spero Therapeutics News Delivered to You Automatically

You’re invited: Biggest crypto event of 2024 (Ad)

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

SPRO Media Mentions By Week

SPRO Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

SPRO
News Sentiment
▼
0.59

0.53
▲
Average
Medical
News Sentiment

SPRO News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

SPRO Articles
This Week
▼
1

1
▲
SPRO Articles
Average Week

Get Spero Therapeutics News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:SPRO) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Spero Therapeutics (SPRO) News Today

SPRO Media Mentions By Week

SPRO Media Sentiment

SPRO News Coverage

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info